Topics

Human medicines European public assessment report (EPAR): Remicade, infliximab, Spondylitis, Ankylosing,Arthritis, Rheumatoid,Psoriasis,Crohn Disease,Arthritis, Psoriatic,Colitis, Ulcerative, Date of authorisation: 13/08/1999, Revision: 54, Status: Author

09:41 EDT 10 Jul 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Remicade, infliximab, Spondylitis, Ankylosing,Arthritis, Rheumatoid,Psoriasis,Crohn Disease,Arthritis, Psoriatic,Colitis, Ulcerative, Date of authorisation: 13/08/1999, Revision: 54, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Remicade, infliximab, Spondylitis, Ankylosing,Arthritis, Rheumatoid,Psoriasis,Crohn Disease,Arthritis, Psoriatic,Colitis, Ulcerative, Date of authorisation: 13/08/1999, Revision: 54, Status: Author

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Remicade, infliximab, Spondylitis, Ankylosing,Arthritis, Rheumatoid,Psoriasis,Crohn Disease,Arthritis, Psoriatic,Colitis, Ulcerative, Date of authorisation: 13/08/1999, Revision: 54, Status: Author"

Quick Search

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...